{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:22:11Z","timestamp":1777616531004,"version":"3.51.4"},"reference-count":15,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,2,17]]},"abstract":"<jats:p>\n            We present an\n            <jats:italic>in vitro<\/jats:italic>\n            susceptibility assay for\n            <jats:named-content content-type=\"genus-species\">Madurella mycetomatis<\/jats:named-content>\n            hyphae using resazurin for endpoint reading. Using this assay, reproducible MICs were obtained for amphotericin B, itraconazole, voriconazole, posaconazole, terbinafine, and micafungin.\n          <\/jats:p>","DOI":"10.1128\/aac.01338-20","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T14:29:49Z","timestamp":1608042589000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Development and Validation of an\n            <i>In Vitro<\/i>\n            Resazurin-Based Susceptibility Assay against\n            <i>Madurella mycetomatis<\/i>"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-6909","authenticated-orcid":true,"given":"S. O.","family":"Abd Algaffar","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Science &amp; Technology, Omdurman, Sudan"},{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Verbon","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-8783","authenticated-orcid":true,"given":"W. W. J.","family":"van de Sande","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-7040","authenticated-orcid":true,"given":"S. A.","family":"Khalid","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Science &amp; Technology, Omdurman, Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002942"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.7.2742-2746.2004"},{"key":"e_1_3_1_4_2","volume-title":"Assay guidance manual [Internet]","author":"Riss TL","year":"2004","unstructured":"Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L. 2004. Cell viability assays. 2013 May 1 [updated 2016 Jul 1]. In Markossian S, Sittampalam GS, Grossman A, Brimacombe K, Arkin M, Auld D, Austin CP, Baell J, Caaveiro JMM, Chung TDY, Coussens NP, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Haas JV, Hoare SRJ, Inglese J, Iversen PW, Kahl SD, Kales SC, Kirshner S, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Saradjian P, Trask OJ, Jr, Weidner JR, Wildey MJ, Xia M, Xu X (ed), Assay guidance manual [Internet]. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01606.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.4.1364-1368.2005"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01045-10"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01546-09"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06534.x"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.75.1106"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1590\/s0036-46652005000600006"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00359-X"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231871"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.14.32"},{"key":"e_1_3_1_15_2","first-page":"47","article-title":"Treatment of eumycetoma and actinomycetoma","volume":"6","author":"Welsh O","year":"1995","unstructured":"Welsh O, Salinas MC, Rodr\u00edguez MA. 1995. Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol 6:47\u201371.","journal-title":"Curr Top Med Mycol"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01532-19"}],"updated-by":[{"DOI":"10.1128\/aac.00149-24","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000}}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01338-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01338-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:52:34Z","timestamp":1645480354000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01338-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,17]]}},"alternative-id":["10.1128\/AAC.01338-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01338-20","relation":{"correction":[{"id-type":"doi","id":"10.1128\/aac.00149-24","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"2020-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01338-20"}}